Pancreatic cancer surgery: comparing two surgical approaches
Part of Cancer, Digestive system clinical trials.
This trial tests two different surgical techniques for removing pancreatic cancer tumors that can be surgically removed. Researchers want to see if operating on the main artery first leads to better outcomes than the standard approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with pancreatic cancer that can be removed by surgery or is borderline resectable (touching but not invading major blood vessels)
- Cancer has not spread to other parts of your body (confirmed by CT scan of chest and abdomen, and MRI of liver)
- Blood tests show a tumor marker (CA 19.9) level of 500 or less
- Age 18 or older and in good enough health to have major surgery (ECOG performance status 0–1)
- Normal kidney and liver function, and adequate blood cell counts
- Live in France and have French social insurance coverage
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of surgery for people with pancreatic head cancer: the usual partial pancreatoduodenectomy (removing part of the pancreas and nearby structures) and a more extensive version that removes additional tissue. The goal is to see which approach works better.
This trial compares two types of surgery to remove tumors that start near the pancreas but not in it. The goal is to see if a newer, less invasive method works as well as the standard approach, which may mean fewer cuts and a faster recovery.
This trial compares two surgical strategies to help prevent return of cancer after surgery for pancreatic body and tail ductal adenocarcinoma. You may be eligible if your cancer looks removable before surgery and your overall health and lab tests are within allowed ranges.
This trial compares two approaches for patients with pancreatic or periampullary cancer that can be surgically removed: getting chemotherapy before surgery (neoadjuvant therapy) versus surgery first. It aims to find out which sequence leads to better outcomes.
This trial compares a modified surgical technique to the standard one for removing pancreatic tumors. It aims to see if the new method lowers the risk of a leak from the pancreas after surgery.
This study compares two ways of doing pancreaticoduodenectomy (a major surgery to remove parts of the pancreas and nearby tissue): minimally invasive (often smaller incisions) versus open surgery. It may help clarify which approach works best when the cancer looks potentially removable.
Hear when a new Pancreatic Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.